A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1862 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-12-01

Study Completion Date

2018-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was designed to compare effectiveness and safety of the surgeries of Ivor-Lewis and Mckeown in patients with esophageal cancer

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Robot-assisted IVOR-LEWIS Esophagectomy

NCT03140189

Clinical or Oncologic Benefits of Robot-assisted IVOR-LEWIS in Esophageal Cancer

UNKNOWN

Outcomes of A Novel Treatment Decision of Patients With Esophageal and Head and Neck Carcinoma Synchronously

NCT03450447

Head and Neck Cancer Esophageal Cancer Stage

UNKNOWN

A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

NCT04217239

Esophageal Cancer

RECRUITING NA

Minimally Invasive Intrathoracic Esophagogastric Side to Side Anastomosis vs. End to Side Anastomosis

NCT05812495

Epiphora Due to Insufficient Drainage, Left Side Epiphora Due to Insufficient Drainage, Right Side

UNKNOWN NA

Health-related Quality of Life of Patients With Esophageal Cancer After Surgery

NCT01349517

Esophageal Cancer

UNKNOWN PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The trial is a multi-centre real-world non-interventional observational study. The study was designed to compare effectiveness and safety of the minimally invasive surgeries of Ivor-Lewis and Mckeown in the Chinese patients with IA-IIIB esophageal cancer via a retrospectively review method based on the study data on patient demographic/tumor biological characteristics and clinical treatments.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with the surgery of Ivor-Lewis

Pathologically diagnosed IA-IIIB patients with esophageal cancer who received minimally invasive surgery of Ivor-Lewis

Surgeries

Intervention Type PROCEDURE

Minimally invasive surgeries of Ivor-Lewis and Mckeown

Patients with the surgery of Mckeown

Pathologically diagnosed IA-IIIB patients with esophageal cancer who received minimally invasive surgery of Mckeown

Surgeries

Intervention Type PROCEDURE

Minimally invasive surgeries of Ivor-Lewis and Mckeown

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgeries

Minimally invasive surgeries of Ivor-Lewis and Mckeown

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Pathologically diagnosed middle and lower thoracic IA-IIIB esophageal cancer after surgeries;
* Patients who received minimally invasive radical dissections of Ivor-Lewis and Mckeown;
* Patients who received tubular gastroesophageal reconstruction;

Exclusion Criteria

* Patients complicated with arrhythmia, or serious disfunctions of heart, lung, liver, and kidney before surgeries;
* Patients with second primary tumors;
* Patients who received abdominal or thoracic surgeries;
* Patients who received gastrostomy or nesteostomy before surgeries;
* Patients with suspected cervical lymph metastases (in the subgroup of the patients who received the surgery of Mckeown)

Eligible Sex

ALL

Accepts Healthy Volunteers

No